Intel Capital, an investor since 2011, achieved an exit in a Chinese IPO, and has now exited a quarter of its 120 China-based portfolio companies.

B-Soft, a China-based healthcare company backed by US-listed chipmaker Intel, has floated on the ChiNext board of the Shenzhen Stock Exchange at RMB16.82 ($2.60) per share.

Intel Capital, which acts as Intel’s corporate venturing arm, invested an undisclosed amount in B-Soft in 2011, 14 years after it was founded in 1997 by Ge Hang in Hangzhou, Zhejiang province.

Arvind Sodhani, executive vice president of Intel and president of Intel Capital, said: “B-Soft provides comprehensive IT solutions and services for hospitals…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?